MedTrace Logo

Efficacy of Continuous Sciatic Nerve Block in Diabetic Foot Patients

NCT04212325 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-05-25

No results posted yet for this study

Summary

Patients who underwent surgery for diabetic foot were divided into three groups: sciatic nerve block (Group B), continuous nerve catheter (Group C) . Group B patients underwent preoperative popliteal ultrasound guided peripheral nerve blockage. 20 ml of 0.25% bupivacaine was administered. In Group C patients, 20% bupivacaine 20 ml was applied to the sciatic nerve with a peripheral nerve catheter and continuous infusion was started with patient controlled analgesia device.

Conditions

  • Diabetic Foot
  • Regional Anesthesia
  • Catheter Blockage
  • Wound Heal

Interventions

PROCEDURE

Group C (Continuous sciatic nerve block)

Patients randomized to this group will receive a sciatic nerve block with the catheter tip insertion at the popliteal location 1-3 cm cephalad to the sciatic bifurcation. After Catheter placement outcome measures will be assessed.

PROCEDURE

Group S (sciatic nerve block)

Patients randomized to this group will receive a sciatic nerve block at the popliteal location 1-3 cm cephalad to the sciatic bifurcation. After single injection sciatic nerve block, outcome measures will be assessed.

Sponsors & Collaborators

  • Gulhane School of Medicine

    lead OTHER

Principal Investigators

  • Mehmet B EŞKİN, M.D. · Gulhane Training and Research Hospital

  • Kerim B. Yılmaz, M.D. · Gulhane Training and Research Hospital

  • Gökhan Özkan, M.D. · Gulhane Training and Research Hospital

  • Erhan Güven, M.D. · Gulhane Training and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-10
Primary Completion
2021-12-01
Completion
2023-01-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04212325 on ClinicalTrials.gov